The Discounted Cash Flow (DCF) valuation of Creo Medical Group PLC (CREO.L) is (4,725.65) GBP. With the latest stock price at 14.10 GBP, the upside of Creo Medical Group PLC based on DCF is -33615.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 9.0% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (14,654.82) - (2,877.61) | (4,725.65) |
| Upside | -104034.9% - -20508.6% | -33615.3% |